What Researchers Did
Researchers performed a bibliometric analysis of scientific publications to identify current trends and key areas in the prevention and management of radiation dermatitis.
What They Found
Analyzing 459 articles published between 1995 and 2024, the study revealed an increasing trend in publications, with the United States (125), China (73), and Canada (45) being the top three contributing countries. Key research areas include the role of radiotherapy dose fractionation, atmospheric pressure cold plasma, and hyperbaric oxygen therapy (HBOT) in managing radiation dermatitis.
What This Means for Canadian Patients
For Canadian patients experiencing radiation dermatitis, this research highlights a growing focus on effective prevention and management strategies, including the potential role of HBOT. This ongoing investigation into various treatments offers promise for improved care and better outcomes for those affected by this challenging side effect of radiation therapy.
Canadian Relevance
Canada was identified as the third-highest publishing country in this field, contributing 45 articles. Radiation dermatitis is a recognized complication of cancer treatment, and hyperbaric oxygen therapy is a Health Canada-recognized indication for certain radiation injuries.
Study Limitations
As a bibliometric analysis, this study reviews existing literature trends rather than providing new clinical evidence or patient outcomes.